IL6 and myeloid sarcoma: Although no significant differences in IL-6 levels between the HEP and LEP were observed in healthy individuals within our study, IL-6 levels in the MS group showed an increasing trend during the HEP (p = 0.059), suggesting heightened inflammatory responses in metabolically compromised individuals.